Expression of CD56 As A Prognostic Factor in Multiple Myeloma

Reviewer: John P. Plastaras, MD, PhD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 23 de marzo del 2007

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Revised Staging System Prognostic for Multiple Myeloma

Aug 4, 2015

ISS plus chromosomal abnormalities, lactate dehydrogenase prognostic in multiple myeloma

Adverse Prognostic Factor ID'd in Operable Breast Cancer

Oct 31, 2012

HER-2 2+/HER-2 correlates with worse disease-free survival with time-dependent effect noted

Incidence of Specific Cancers Up for WTC Rescue Workers

Dec 19, 2012

Prostate, thyroid cancers, multiple myeloma up for world trade center rescue/recovery workers